Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification.
about
Non-Canonical Thinking for Targeting ALK-Fusion Onco-Proteins in Lung Cancer.Histologic Grade Is Predictive of Incidence of Epidermal Growth Factor Receptor Mutations in Metastatic Lung Adenocarcinoma.FGFR1 gene amplification in squamous cell carcinomas of the lung: a potential favorable prognostic marker for women and for patients with advanced cancer.The function and therapeutic targeting of anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC).Anaplastic lymphoma kinase (ALK)-rearranged pulmonary pleomorphic carcinoma successfully treated with crizotinib.Update on Immunohistochemistry for the Diagnosis of Lung Cancer.Gram-negative bacteria facilitate tumor progression through TLR4/IL-33 pathway in patients with non-small-cell lung cancer.Clinicopathological Characteristics and Mutations Driving Development of Early Lung Adenocarcinoma: Tumor Initiation and Progression.Correlations Between mRNA Levels of Centrosomal Protein 55 (CEP55) and Clinical Features of Patients with Lung Cancer.Prognostic value of localization of epidermal growth factor receptor in lung adenocarcinoma.
P2860
Q46793262-1B68C0E1-30FA-4D2D-82AF-7EEEDD0F2D43Q48132127-BA82D6D6-506B-42DE-BE2D-56623AE45E65Q48360381-A2E4A9E2-C0B6-473E-9891-6B95786ECF50Q49887874-E0E83D9C-A4CE-4C38-A95B-BB69F342A3EFQ50135936-3CEF2C9B-37D5-41AC-B8BF-3B4137FB5D13Q51733982-F1F4FAC3-7AA1-4E45-ABCA-ACD8285DE18CQ52641579-6E89D3B3-22FF-4D57-A79F-DA00DEFF91ECQ54980290-D3438810-6D27-4DB7-AFC9-62F1343AEAF5Q55080656-3292BA8E-E184-4669-90BE-1E5479B6EE6BQ55460041-DB2AA716-5813-4F50-8E30-2184D6DEFDC2
P2860
Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification.
@en
Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification.
@nl
type
label
Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification.
@en
Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification.
@nl
prefLabel
Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification.
@en
Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification.
@nl
P2860
P356
P1476
Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification.
@en
P2860
P356
10.3389/FONC.2017.00193
P577
2017-08-28T00:00:00Z